These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
857 related articles for article (PubMed ID: 21611961)
21. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. Okamoto M; Murai J; Yoshikawa H; Tsumaki N J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523 [TBL] [Abstract][Full Text] [Related]
23. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Tang CH; Yang RS; Chien MY; Chen CC; Fu WM Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360 [TBL] [Abstract][Full Text] [Related]
24. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. Korchynskyi O; Dechering KJ; Sijbers AM; Olijve W; ten Dijke P J Bone Miner Res; 2003 Jul; 18(7):1177-85. PubMed ID: 12854827 [TBL] [Abstract][Full Text] [Related]
25. Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells). Terkeltaub RA; Johnson K; Rohnow D; Goomer R; Burton D; Deftos LJ J Bone Miner Res; 1998 Jun; 13(6):931-41. PubMed ID: 9626624 [TBL] [Abstract][Full Text] [Related]
26. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway. Uemura T; Ohta Y; Nakao Y; Manaka T; Nakamura H; Takaoka K Bone; 2010 Oct; 47(4):756-65. PubMed ID: 20637325 [TBL] [Abstract][Full Text] [Related]
27. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895 [TBL] [Abstract][Full Text] [Related]
28. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905 [TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. Fromigué O; Marie PJ; Lomri A J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905 [TBL] [Abstract][Full Text] [Related]
30. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts. Zhou H; Hammonds RG; Findlay DM; Martin TJ; Ng KW J Cell Physiol; 1993 Apr; 155(1):112-9. PubMed ID: 8385674 [TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α. Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945 [TBL] [Abstract][Full Text] [Related]
32. The effect of timing in the administration of hepatocyte growth factor to modulate BMP-2-induced osteoblast differentiation. Kawasaki T; Niki Y; Miyamoto T; Horiuchi K; Matsumoto M; Aizawa M; Toyama Y Biomaterials; 2010 Feb; 31(6):1191-8. PubMed ID: 19913294 [TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice. Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545 [TBL] [Abstract][Full Text] [Related]
35. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858 [TBL] [Abstract][Full Text] [Related]
36. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Lou J; Tu Y; Li S; Manske PR Biochem Biophys Res Commun; 2000 Feb; 268(3):757-62. PubMed ID: 10679278 [TBL] [Abstract][Full Text] [Related]
37. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2. Gutierrez J; Osses N; Brandan E J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells. Yeh LC; Betchel KP; Lee JC J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105 [TBL] [Abstract][Full Text] [Related]
39. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Akiyama S; Katagiri T; Namiki M; Yamaji N; Yamamoto N; Miyama K; Shibuya H; Ueno N; Wozney JM; Suda T Exp Cell Res; 1997 Sep; 235(2):362-9. PubMed ID: 9299160 [TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Deckers MM; van Bezooijen RL; van der Horst G; Hoogendam J; van Der Bent C; Papapoulos SE; Löwik CW Endocrinology; 2002 Apr; 143(4):1545-53. PubMed ID: 11897714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]